Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Perfusion Tech ApS
APS
Active
Advertising protection
CVR 38238213
Viborggade 70D, 2100
København Ø
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2016 · 9 years old
10 employees
perfusiontech.com
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Perfusion Tech ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-0M
-1M
-1M
-1M
-1M
2021
-4M
2022
-5M
2023
-9M
2024
-6M
2025
EBITDA
DKK millions
0M
-5M
-10M
-15M
-20M
-2M
2021
-8M
-300%
2022
-11M
-37%
2023
-16M
-45%
2024
-14M
+13%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
-1.067
-4.201
-5.414
-9.022
-6.143
Staff expenses
-1.346
-3.362
-5.292
-7.373
-8.275
EBITDA
-2.413
-7.563
-10.706
-16.395
-14.418
Depreciation & amort.
-0
-0
-0
-7
-17
EBIT
-2.413
-7.563
-10.706
-16.402
-14.435
Net financials
-280
-270
-306
-289
-393
Profit before tax
-2.693
-7.833
-11.013
-16.691
-14.828
Tax
-575
-1.277
-1.468
-2.221
-2.103
Net profit
-2.118
-6.556
-9.545
-14.470
-12.725
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
1.264
4.888
8.832
5.585
4.587
Equity
-3.932
1.170
2.873
2.114
-9.641
Long-term debt
4.575
3.116
2.972
1.501
0
Short-term debt
622
602
2.987
1.970
14.227
Total debt
5.197
3.718
5.959
3.471
14.227
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-1441816500.0%
This company
2021
2025
Equity ratio
-210.2%
This company
38.2%
Market median
-650% vs market
2021
2025
Return on equity
-1272470800.0%
This company
18.4%
Market median
-6915602274% vs market
2021
2025
Net profit margin (of gross profit)
-1272470800.0%
This company
2021
2025
Asset turnover (of gross profit)
-1.34×
This company
2021
2025
Debt / equity
1.48×
This company
0.62×
Market median
-139% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Perfusion Tech ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
